Lupin has launched Lanthanum Carbonate Chewable Tablets 500 mg (base), 750 mg (base), and 1000 mg (base). Lupin’s alliance partner Natco had received an approval from the United States Food and Drug Administration (USFDA) earlier.
Lanthanum Carbonate Chewable Tablets 500 mg (base), 750 mg (base), and 1000 mg (base) are generic equivalents of Shire Development LLC’s Fosrenol Chewable Tablets 500 mg, 750 mg and 1000 mg. Lanthanum Carbonate Chewable Tablets 500 mg (base), 750 mg (base), and 1000 mg (base) are indicated to reduce serum phosphate in patients with end stage renal disease (ESRD). As per IMS MAT June 2017, Fosrenol Chewable Tablets has US sales of $122.4 million.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.00 |
Dr. Reddys Lab | 6260.00 |
Cipla | 1419.55 |
Zydus Lifesciences | 988.00 |
Lupin | 1647.75 |
View more.. |